These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23354024)

  • 1. Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder.
    Modi HR; Basselin M; Taha AY; Li LO; Coleman RA; Bialer M; Rapoport SI
    Biochim Biophys Acta; 2013 Apr; 1831(4):880-6. PubMed ID: 23354024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
    Modi HR; Basselin M; Rapoport SI
    Bipolar Disord; 2014 Dec; 16(8):875-80. PubMed ID: 25041123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
    Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
    Modi HR; Ma K; Chang L; Chen M; Rapoport SI
    Psychiatry Res; 2017 Aug; 254():279-283. PubMed ID: 28500975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.
    Bazinet RP; Weis MT; Rapoport SI; Rosenberger TA
    Psychopharmacology (Berl); 2006 Jan; 184(1):122-9. PubMed ID: 16344985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
    Rapoport SI
    ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
    Chang MC; Contreras MA; Rosenberger TA; Rintala JJ; Bell JM; Rapoport SI
    J Neurochem; 2001 May; 77(3):796-803. PubMed ID: 11331408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
    Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
    Biol Psychiatry; 2006 Mar; 59(5):401-7. PubMed ID: 16182257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
    Kuwata H; Hara S
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
    Rao JS; Lee HJ; Rapoport SI; Bazinet RP
    Mol Psychiatry; 2008 Jun; 13(6):585-96. PubMed ID: 18347600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.
    Ramadan E; Basselin M; Taha AY; Cheon Y; Chang L; Chen M; Rapoport SI
    Neuropharmacology; 2011 Dec; 61(8):1256-64. PubMed ID: 21839100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar disorder and mechanisms of action of mood stabilizers.
    Rapoport SI; Basselin M; Kim HW; Rao JS
    Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    Bazinet RP
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood-stabilizers target the brain arachidonic acid cascade.
    Rao JS; Rapoport SI
    Curr Mol Pharmacol; 2009 Jun; 2(2):207-14. PubMed ID: 20021459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
    Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
    Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
    Lee HJ; Rao JS; Rapoport SI; Bazinet RP
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):239-46. PubMed ID: 18042366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphology.
    Shimshoni JA; Dalton EC; Watson P; Boris Y; Bialer M; Harwood AJ
    Neuropharmacology; 2009 Mar; 56(4):831-7. PubMed ID: 19705552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide increases the availability of arachidonic acid for oxidative metabolism by inhibiting acylation into phospholipids in the alveolar macrophage.
    Sporn PH; Marshall TM; Peters-Golden M
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):307-16. PubMed ID: 1520493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.
    Basselin M; Chang L; Chen M; Bell JM; Rapoport SI
    Neurochem Res; 2008 Nov; 33(11):2229-40. PubMed ID: 18461450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.